Adze Biotechnology Inc

Amendment
CIK: 0001787508·Biotechnology·DELAWARE·Filed: Nov 16, 2026
Total Offering

$11,753,969

Amount Sold

$9,253,969

Investors

28

First Sale

Mar 10, 2023

Offering Details

Type
Equity
Exemptions
Rule 506(c)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Sidney Hopps
Related Person
G. Patrick Sage, II
Related Person
Gabriel Raviv
Related Person
Brendan Kenny
Related Person
Andrew Kinsella
Related Person

Company

Adze Biotechnology Inc

2332 GALIANO STREET, 2ND FL

CORAL GABLES, FL, 33134

9177439401

SEC Filing

0001787508-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free